Effectiveness and Safety of Niclosamaide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management: Randomized controlled clinical trial

Ahmed S. Abdulamir, Faiq I. Gorial, Sattar Jabar Saadi, Mohammed Fauzi Maulood, Hashim Ali Hashim, Manal K. abdulrrazaq
doi: https://doi.org/10.1101/2021.06.10.21258709

Article usage

Article usage: June 2021 to July 2025

AbstractFullPdf
Jun 2021144413179
Jul 20212494256
Aug 20213047945
Sep 202118311543
Oct 20211182342
Nov 20211034043
Dec 2021884119
Jan 2022664517
Feb 2022462011
Mar 2022501711
Apr 202241915
May 2022672015
Jun 202243410
Jul 202239510
Aug 20222597
Sep 2022421212
Oct 202250149
Nov 20223158
Dec 202229128
Jan 2023403810
Feb 202331145
Mar 202328168
Apr 20231986
May 202317610
Jun 20231073
Jul 202317210
Aug 2023251115
Sep 202315611
Oct 20231633
Nov 2023231313
Dec 20231744
Jan 20242213
Feb 20241575
Mar 202423104
Apr 202419139
May 20241535
Jun 20241978
Jul 2024341014
Aug 20242969
Sep 20242536
Oct 20241736
Nov 202417313
Dec 20241426
Jan 202514129
Feb 202516217
Mar 2025332815
Apr 2025262613
May 2025242711
Jun 2025351010
Jul 2025363
Back to top
Posted June 17, 2021.
Download PDF
Data/Code
Email
Effectiveness and Safety of Niclosamaide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management: Randomized controlled clinical trial
Ahmed S. Abdulamir, Faiq I. Gorial, Sattar Jabar Saadi, Mohammed Fauzi Maulood, Hashim Ali Hashim, Manal K. abdulrrazaq
medRxiv 2021.06.10.21258709; doi: https://doi.org/10.1101/2021.06.10.21258709
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area